Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2010, Article ID 957507, 5 pages
http://dx.doi.org/10.1155/2010/957507
Case Report

Obstetrical Complications and Outcome in Two Families with Hereditary Angioedema due to Mutation in the F12 Gene

1Université Paris-Sud, 92141 Clamart, France
2AP-HP, Service de Gynécologie-Obstétrique et Médecine de la Reproduction, Hôpital Antoine Béclère, 92141 Clamart, France
3INSERM, U 782, 92140 Clamart, France
4AP-HP, Service de Réanimation Médicale, Hôpital Antoine Béclère, 92141 Clamart, France
5INSERM, U 764, 92140 Clamart, France
6AP-HP, Service d'Hématologie Biologique, Hôpital Antoine Béclère, 92141 Clamart, France
7INSERM, U 770, 94270 Le Kremlin Bicêtre, France
8AP-HP, Département d'Immunologie, Immunologie Biologique, Hôpital Européen Georges Pompidou, Université Paris V, 75908 Paris, France
9INSERM, U 255, 75015 Paris, France

Received 4 December 2009; Revised 16 March 2010; Accepted 16 March 2010

Academic Editor: M. A. Williams

Copyright © 2010 Olivier Picone et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Agostoni, E. Aygören-Pürsün, K. E. Binkley et al., “Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond,” Journal of Allergy and Clinical Immunology, vol. 114, no. 3, supplement, pp. S51–S131, 2004. View at Publisher · View at Google Scholar · View at PubMed
  2. M. Cicardi, L. Zingale, A. Zanichelli, E. Pappalardo, and B. Cicardi, “C1 inhibitor: molecular and clinical aspects,” Springer Seminars in Immunopathology, vol. 27, no. 3, pp. 286–298, 2005. View at Publisher · View at Google Scholar · View at PubMed
  3. A. E. Davis III, “The pathophysiology of hereditary angioedema,” Clinical Immunology, vol. 114, no. 1, pp. 3–9, 2005. View at Publisher · View at Google Scholar · View at PubMed
  4. M. M. Gompels, R. J. Lock, M. Abinun et al., “C1 inhibitor deficiency: consensus document,” Clinical and Experimental Immunology, vol. 139, no. 3, pp. 379–394, 2005. View at Publisher · View at Google Scholar · View at PubMed
  5. Y. Karim, H. Griffiths, and S. Deacock, “Normal complement C4 values do not exclude hereditary angioedema,” Journal of Clinical Pathology, vol. 57, no. 2, pp. 213–214, 2004. View at Publisher · View at Google Scholar
  6. M. D. Tarzi, A. Hickey, T. Förster, M. Mohammadi, and H. J. Longhurst, “An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema,” Clinical and Experimental Immunology, vol. 149, no. 3, pp. 513–516, 2007. View at Publisher · View at Google Scholar · View at PubMed
  7. T. Bowen, M. Cicardi, K. Bork et al., “Hereditary angioedema: a current state-of- the -art review,VII:canadian Hungarian 2007 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema,” Annals of Allergy, Asthma and Immunology, vol. 100, no. 1 supplement 2, pp. S30–S40, 2008. View at Google Scholar
  8. C. Duponchel, K. Djenouhat, V. Fremeaux-Bacchi, N. Monnier, C. Drouet, and M. Tosi, “Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH,” Human Mutation, vol. 27, no. 3, pp. 295–296, 2006. View at Google Scholar
  9. O. Roche, A. Blanch, C. Duponchel, G. Fontan, M. Tosi, and M. Lopez-Trascasa, “Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohort,” Human Mutation, vol. 26, no. 2, pp. 135–144, 2005. View at Publisher · View at Google Scholar · View at PubMed
  10. K. Bork, S.-E. Barnstedt, P. Koch, and H. Traupe, “Hereditary angioedema with normal C1-inhibitor activity in women,” Lancet, vol. 356, no. 9225, pp. 213–217, 2000. View at Google Scholar
  11. K. Bork, D. Gül, and G. Dewald, “Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men,” British Journal of Dermatology, vol. 154, no. 3, pp. 542–545, 2006. View at Publisher · View at Google Scholar · View at PubMed
  12. K. Bork, D. Gül, J. Hardt, and G. Dewald, “Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course,” American Journal of Medicine, vol. 120, no. 11, pp. 987–992, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. L. Martin, N. Raison-Peyron, M. M. Nothen, S. Cichon, and C. Drouet, “Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene,” Journal of Allergy and Clinical Immunology, vol. 120, no. 4, pp. 975–977, 2007. View at Publisher · View at Google Scholar · View at PubMed
  14. K. E. Binkley and A. Davis III, “Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema,” Journal of Allergy and Clinical Immunology, vol. 106, no. 3, pp. 546–550, 2000. View at Publisher · View at Google Scholar · View at PubMed
  15. K. Bork, K. Wulff, J. Hardt, G. Witzke, and P. Staubach, “Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy,” Journal of Allergy and Clinical Immunology, vol. 124, no. 1, pp. 129–134, 2009. View at Publisher · View at Google Scholar · View at PubMed
  16. G. Dewald and K. Bork, “Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor,” Biochemical and Biophysical Research Communications, vol. 343, no. 4, pp. 1286–1289, 2006. View at Publisher · View at Google Scholar · View at PubMed
  17. L. Bouillet, D. Ponard, H. Rousset, S. Cichon, and C. Drouet, “A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene,” British Journal of Dermatology, vol. 156, no. 5, pp. 1063–1065, 2007. View at Publisher · View at Google Scholar · View at PubMed
  18. J. C. Livingston, K. M. Malik, T. M. Crombleholme, F.-Y. Lim, and B. M. Sibai, “Mirror syndrome: a novel approach to therapy with fetal peritoneal-amniotic shunt,” Obstetrics and Gynecology, vol. 110, no. 2 II, pp. 540–543, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. S. Cichon, L. Martin, H. C. Hennies et al., “Increased activity of coagulation factor XII (Hageman Factor) causes hereditary angioedema type III,” American Journal of Human Genetics, vol. 79, no. 6, pp. 1098–1104, 2006. View at Publisher · View at Google Scholar · View at PubMed
  20. K. Bork, R. Kliest, J. Hardt, and G. Witze, “Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys,” Blood Coagululation and Fibrinolysis, vol. 20, no. 5, pp. 325–332, 2009. View at Google Scholar
  21. N. Nagy, M. W. Greaves, A. Tanaka, J. A. McGrath, and C. E. Grattan, “Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema,” Journal of Dermatological Science, vol. 56, no. 1, pp. 62–64, 2009. View at Publisher · View at Google Scholar · View at PubMed
  22. A. Farsetti, S. Misiti, F. Citarella et al., “Molecular basis of estrogen regulation of Hageman factor XII gene expression,” Endocrinology, vol. 136, no. 11, pp. 5076–5083, 1995. View at Google Scholar
  23. A. D. Altman, J. McLaughlin, R. Schellenberg et al., “Hereditary angioedema managed with low-dose danazol and C1 esterase inhibitor concentrate: a case report,” Journal of Obstetrics and Gynaecology Canada, vol. 28, no. 1, pp. 27–31, 2006. View at Google Scholar
  24. E. D. Han, R. C. MacFarlane, A. N. Mulligan, J. Scafidi, and A. E. Davis III, “Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor,” Journal of Clinical Investigation, vol. 109, no. 8, pp. 1057–1063, 2002. View at Publisher · View at Google Scholar
  25. M. W. Wolff, F. Zhang, J. J. Roberg et al., “Expression of C1 esterase inhibitor by the baculovirus expression vector system: preparation, purification, and characterization,” Protein Expression and Purification, vol. 22, no. 3, pp. 414–421, 2001. View at Publisher · View at Google Scholar · View at PubMed
  26. C. Hermans, “Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report,” Archives of Gynecology and Obstetrics, vol. 276, no. 3, pp. 271–276, 2007. View at Publisher · View at Google Scholar · View at PubMed
  27. W. Kreuz, I. Martinez-Saguer, E. Rusicke, E. Aygören-Pürsün, and T. Klingelbiel, “Management of HAE patients presenting during pregnancy and delivery. A prospective 12-years follow up,” Journal of Allergy and Clinical Immunology, vol. 121, no. 2, p. S98, 2008, abstract 379. View at Google Scholar